A new way to diagnose pancreatic cancer has been developed as a result of collaborative research conducted by experts from Harvard, the Massachusetts Institute of Technology and the Dana-Farber Cancer Institute.
Moreover, this method will be able to detect cancer several years before its manifestation. So, a new way to detect cancer is based on a blood test. Certain amino acids such as valine, isoleucine and leucine are an indicator of the development of pancreatic cancer in the body. And this despite the fact that no other analysis is able to show such substances.
Researchers can't say exactly what the link is between these amino acids and pancreatic cancer. But they suggest that the tumor germ can interfere with metabolic processes, destroying proteins saturated with these amino acids.
Once validated and further researched, this diagnostic method could significantly reduce the number of patients suffering from pancreatic cancer. At the same time, no one refuses more traditional diagnostic methods that have proven their effectiveness over the years.
Add a comment